Ajanta Pharma Buyback 2019
(i) Ajanta Pharma is a specialty pharmaceutical company engaged in the development, manufacturing, and marketing of quality finished dosages. Committed to ‘Serve Health Care Needs Worldwide’, they produce a comprehensive range of specialty products targeting different therapeutic segments for the treatment of patients, customized to each market.
(ii) Their business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales.
(iii) The branded generics business is spread in India and more than 30 emerging countries across Africa, CIS, the Middle East and South East Asia. In India, they have a presence in high growth specialty segments of cardiology, dermatology, ophthalmology and pain management where they have been able to provide consistently innovative products, many being 1st to the market, for patient convenience and compliance.
Buy Back Offer Deal:
|Buyback Type:||Tender Offer|
|Buyback Record Date:||Feb 12 2019|
|Date of Board Meeting approving the proposal:||Jan 30 2019|
|Date of Public Announcement:||Jan 30 2019|
|Buyback Offer Size:||5.22%|
|Buyback Number of Shares:||7,69,230|
|Buyback Price:||₹ 1300 Per Equity Share|
Details of Buyback:
Salient financial parameters:
How to Participate in buyback?
Profit from the buyback on the bases of acceptance Ratio:
|Amount Invested in Buyback||1,67,538||1,67,538||1,67,538||1,67,538|
|No. of Shares buyback||50||76||114||153|